All Editorial articles – Page 201
-
NewsTeam-up of two new substances paves the way for new antibiotics
A new study shows how a combination of two new substances effectively kills methicillin-resistant Staphylococcus aureus (MRSA).
-
NewsCOVID-19 infection alters gene transcription of olfactory mucosal cells in Alzheimer’s disease
A new study identifies alterations in the transcriptomic signatures in human olfactory mucosal cells of individuals with Alzheimer’s disease following SARS-CoV-2 infection, potentially contributing to exacerbated COVID-19 outcomes.
-
NewsEMA gives positive opinion to first oral treatment of acute form of sleeping sickness
The EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense).
-
NewsOmicron induces cellular senescence in human lung, study finds
Researchers investigating the influence of defined altered spike formations have confirmed that the Omicron variant induces cellular senescence in human lungs of COVID-19 patients.
-
NewsResearchers pave way for next generation COVID-19 immunization strategies
A vaccine booster delivered directly to mucosal site of infection enhances protection against COVID-19 infection in non-human primates, a new study reveals.
-
NewsRisk of death reduces after COVID-19 vaccine but protection wanes after six months
The risk of death from COVID-19 decreases significantly after vaccination but this protection diminishes after six months, providing evidence for continued booster doses, a new study has found.
-
NewsAncient DNA reveals how a chicken virus evolved to become more deadly
Scientists have used ancient DNA to trace the evolution of Marek’s Disease Virus (MDV), showing how viruses evolve to become more virulent and could lead to the development of better ways to treat viral infections.
-
NewsDiverse gut bacteria communities protect against harmful pathogens by nutrient blocking
A new study demonstrates that diverse communities of resident bacteria can protect the human gut from disease-causing microorganisms. However, this protective effect is lost when only single species of gut bacteria are present.
-
NewsNew understanding of ancient genetic parasite may spur medical breakthroughs
Scientists have published the first high-resolution images and structural details of a virus-like element known as LINE-1, describing it as “an ancient genetic parasite” that is one of the most common parts of human DNA.
-
NewsCockroaches can transmit antimicrobial resistance genes between groups
A new paper describes a study of antimicrobial resistance (AMR) transmission among cockroaches, with implications for AMR transmission in humans.
-
NewsGut bacteria of malnourished children benefit from key elements in therapeutic food
Researchers investigating a new therapeutic food aimed at repairing malnourished children’s underdeveloped gut microbiomes has identified key, naturally occurring biochemical components and the important bacterial strains that process these components.
-
News3G microbial cell factories: achieving sustainable goals with engineered microorganisms
Scientists review the progress made in the development of artificial biological systems for 3G refineries over the last decade.
-
NewsScientists reveal rare enzyme role change with bacterial defense system assembly
A never-before-seen phenomenon in a protein: alone, the enzyme processes DNA and RNA but, when bound to another protein as part of a defense system, interacts with a completely different type of compound to help bacteria commit suicide.
-
NewsMaking probiotics more widely applicable through ‘CRISPR’ engineering
Scientists review the recent progress and challenges in the production and use of genetically modified probiotics.
-
NewsInfection with stomach bacteria may increase risk of Alzheimer’s disease
Infection with the stomach bacterium Helicobacter pylori could increase the risk of developing Alzheimer’s disease. In people over the age of 50, the risk following a symptomatic infection can be an average of 11 per cent higher.
-
News€20 million EIB venture debt financing to support microbiome research and development
The EIB has signed €20 million in venture debt financing with Belgian microbiome health company The Akkermansia Company to accelerate the R&D and commercial activities around the Akkermansia muciniphila bacterium.
-
NewsMpox vaccine triggers equally strong immune response in smaller doses
Delivering the two-dose mpox vaccine in smaller than the usual FDA-approved doses produced a detectable immune response. This also occurred regardless of whether people were living with or without HIV.
-
News Researchers develop a novel dry-powder inhaled vaccine platform
Researchers have developed a single-dose, dry-powder, inhalable vaccine platform using nano-micro composite multilevel structures, which is effective in blocking respiratory viral infection and transmission in animal models.
-
News‘Long flu’ has emerged as a consequence similar to long COVID
A new study shows patients hospitalized for flu or COVID-19 face an increased risk of long-term health problems and death.
-
NewsNovel early-detection method aims to stem disease spread in animal trade
Researchers have described a simplified method to detect a deadly fungus killing European salamanders - Batrachochytrium salamandrivorans, or Bsal.